Search hospitals > Wisconsin > Green Bay
Green Bay Oncology Limited at Saint Mary's Hospital
Claim this profileGreen Bay, Wisconsin 54303
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Relapse
Conducts research for Stomach Cancer
260 reported clinical trials
4 medical researchers
Summary
Green Bay Oncology Limited at Saint Mary's Hospital is a medical facility located in Green Bay, Wisconsin. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Relapse, Stomach Cancer and other specialties. Green Bay Oncology Limited at Saint Mary's Hospital is involved with conducting 260 clinical trials across 314 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Anthony J. Jaslowski, and Jonathan E. Tammela.Area of expertise
1Skin Cancer
Global LeaderStage III
Stage IV
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Matthew L. RyanSaint Vincent Hospital Cancer Center Green Bay1 year of reported clinical research
Expert in Skin Cancer
Studies Relapse
53 reported clinical trials
120 drugs studied
Brian L. BurnetteSaint Vincent Hospital Cancer Center Green Bay5 years of reported clinical research
Expert in Skin Cancer
Studies Breast Cancer
31 reported clinical trials
85 drugs studied
Anthony J. JaslowskiSaint Vincent Hospital Cancer Center Green Bay6 years of reported clinical research
Studies Skin Cancer
Studies Breast Cancer
27 reported clinical trials
48 drugs studied
Jonathan E. TammelaGreen Bay Oncology at Saint Vincent Hospital13 years of reported clinical research
Studies Fallopian Tube Cancer
Studies Peritoneal Carcinomatosis
1 reported clinical trial
5 drugs studied
Clinical Trials running at Green Bay Oncology Limited at Saint Mary's Hospital
Lung Cancer
ALK Gene Rearrangement
Skin Cancer
Non-Small Cell Lung Cancer
Anaplastic Large Cell Lymphoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Green Bay Oncology Limited at Saint Mary's Hospital?
Green Bay Oncology Limited at Saint Mary's Hospital is a medical facility located in Green Bay, Wisconsin. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Relapse, Stomach Cancer and other specialties. Green Bay Oncology Limited at Saint Mary's Hospital is involved with conducting 260 clinical trials across 314 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Anthony J. Jaslowski, and Jonathan E. Tammela.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.